CIK 0001356090 · Non-accelerated filer<br>Smaller reporting company
PRECIGEN, INC.
Sign in to watch- Ticker
- PGEN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 301-556-9900
- Business address
- 20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, 20876
- Former names
- INTREXON CORP
- Open-market buys, last 90 days
- $24,662
- in 1 filing
- Open-market sales, last 90 days
- $2,345,145
- in 3 filings, $969K under 10b5-1 plans
Net −$2,320,483. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-23 | Thomasian Harry Jr. Chief Financial Officer | Option exercise · Restricted Stock Units | −7,291 | 80,209 | ||
| 2026-08-23 | Shah Rutul R Chief Operating Officer | Option exercise 10b5-1 | +7,500 | 472,512 | ||
| 2026-08-23 | Shah Rutul R Chief Operating Officer | Shares withheld for taxes 10b5-1 | −3,647 | $7.20 | $26K | 468,865 |
| 2026-08-23 | Shah Rutul R Chief Operating Officer | Option exercise · Restricted Stock Units 10b5-1 | −7,500 | 57,292 | ||
| 2026-08-23 | Tennant Phil Chief Commercial Officer | Option exercise 10b5-1 | +5,208 | 144,577 | ||
| 2026-08-23 | Tennant Phil Chief Commercial Officer | Shares withheld for taxes 10b5-1 | −2,585 | $7.20 | $19K | 141,992 |
| 2026-08-23 | Tennant Phil Chief Commercial Officer | Option exercise · Restricted Stock Units 10b5-1 | −5,208 | 57,292 | ||
| 2026-08-23 | Sabzevari Helen President and CEO | Option exercise | +20,833 | 3,789,705 | ||
| 2026-08-23 | Sabzevari Helen President and CEO | Shares withheld for taxes | −10,184 | $7.20 | $73K | 3,779,521 |
| 2026-08-23 | Sabzevari Helen President and CEO | Option exercise · Restricted Stock Units | −20,833 | 229,167 | ||
| 2026-08-21 | AGEE NANCY H Director | Purchase | +3,411 | $7.23 | $25K | 309,187 |
| 2026-08-21 | Shah Rutul R Chief Operating Officer | Option exercise 10b5-1 | +34,658 | $2.33 | $81K | 499,670 |
| 2026-08-21 | Shah Rutul R Chief Operating Officer | Sale 10b5-1 | −34,658 | $7.50 | $260K | 465,012 |
| 2026-08-21 | Shah Rutul R Chief Operating Officer | Option exercise · Option to Purchase Common Stock (Right to Buy) 10b5-1 | −34,658 | 88,646 | ||
| 2026-08-06 | Shah Rutul R Chief Operating Officer | Sale 10b5-1 | −32,739 | $6.86 | $225K | 465,012 |
| 2026-08-03 | Shah Rutul R Chief Operating Officer | Option exercise 10b5-1 | +33,772 | $2.33 | $79K | 531,523 |
| 2026-08-03 | Shah Rutul R Chief Operating Officer | Sale 10b5-1 | −33,772 | $6.50 | $220K | 497,751 |
| 2026-08-03 | Shah Rutul R Chief Operating Officer | Option exercise · Option to Purchase Common Stock (Right to Buy) 10b5-1 | −33,772 | 123,304 | ||
| 2026-07-31 | Thomasian Harry Jr. Chief Financial Officer | Sale 10b5-1 | −100,000 | $6.06 | $606K | 254,535 |
| 2026-07-01 | Thomasian Harry Jr. Chief Financial Officer | Sale 10b5-1 | −171,429 | $5.53 | $948K | 354,535 |
Page 2 of 26 · 502 trades